Gastrointestinal Cancer News

Increased use of fecal immunochemical testing correlated with more colorectal cancer screenings and early-stage diagnoses amid the COVID-19 pandemic, according to research in JAMA Network Open.

When the COVID-19 pandemic began in the United States last year, state and local governments mandated shelter-in-place orders, which upended the practice of medicine.

Low-dose aspirin suppressed the recurrence of colorectal polyps in patients with familial adenomatous polyposis, according to research in The Lancet.

Bristol Myers Squibb announced positive results from its phase 3 CheckMate-648 trial of nivolumab for the treatment of patients with unresectable advanced or metastatic esophageal squamous cell carcinoma.

Working night shifts may interfere with natural 24-hour rhythms in the activity of certain genes related to cancer, leading to increased cancer risk, according to a study published in the Journal of Pineal Research.

Liver transplantation may extend OS compared with portal vein embolization and liver resection for selected patients with advanced colorectal cancer liver metastases and a left-sided primary tumor, according to a study in JAMA Surgery.

The FDA approved a new cetuximab dosage regimen for the treatment of patients with KRAS wild-type, EGFR-expressing colorectal cancer or squamous cell carcinoma of the head and neck, according to a press release.

The diagnostic yield of pancreatic ductal adenocarcinoma was substantial in high-risk mutation carrier but non-existent in mutation-negative proven familial pancreatic cancer kindreds.

The FDA granted breakthrough therapy designation to futibatinib for the treatment of patients with locally advanced or metastatic cholangiocarcinoma with FGFR2 gene rearrangements, according to a press release from the agent’s manufacturer.

The FDA cleared an investigational new drug application for the combination of AFM24 and SNK-01 in patients with solid tumors that express epidermal growth factor receptor, according to a joint press release from each agent’s manufacturer.